Honliv Healthcare, headquartered in China, is a prominent player in the healthcare industry, specialising in the development and manufacturing of high-quality medical devices and healthcare solutions. Founded in 2003, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative products that enhance patient care. With a diverse portfolio that includes advanced wound care products, surgical instruments, and diagnostic equipment, Honliv Healthcare stands out for its commitment to quality and innovation. The company has achieved significant milestones, including various certifications and partnerships that underscore its market position. Recognised for its dedication to improving healthcare outcomes, Honliv Healthcare continues to lead the way in delivering effective and reliable medical solutions.
How does Honliv Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Honliv Healthcare's score of 17 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Honliv Healthcare reported total carbon emissions of approximately 11,520,710 kg CO2e, comprising 2,871,310 kg CO2e from Scope 1 emissions and 8,649,400 kg CO2e from Scope 2 emissions. This represents a decrease from 2021, where total emissions were about 10,540,210 kg CO2e, with Scope 1 emissions at 3,212,250 kg CO2e and Scope 2 emissions at 7,327,960 kg CO2e. In 2020, the company recorded total emissions of around 8,079,450 kg CO2e, with Scope 1 emissions of 3,003,540 kg CO2e and Scope 2 emissions of 5,075,910 kg CO2e. Despite these figures, Honliv Healthcare has not established specific reduction targets or climate pledges, nor does it report any Scope 3 emissions. The emissions data is not cascaded from a parent company, indicating that the figures are independently reported by Honliv Healthcare Management Group Company Limited. The company continues to monitor its emissions and may consider future commitments to enhance its sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | |
---|---|---|---|
Scope 1 | 3,003,540 | 0,000,000 | 0,000,000 |
Scope 2 | 5,075,910 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Honliv Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.